Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Net Income: 2010-2018

Historic Net Income for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$53.2 million.

  • EyePoint Pharmaceuticals' Net Income fell 139.24% to -$14.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$34.6 million, marking a year-over-year decrease of 99.88%. This contributed to the annual value of -$53.2 million for FY2018, which is 187.64% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Net Income stood at -$53.2 million for FY2018, which was down 187.64% from -$18.5 million recorded in FY2017.
  • EyePoint Pharmaceuticals' 5-year Net Income high stood at $8.0 million for FY2015, and its period low was -$53.2 million during FY2018.
  • Moreover, its 3-year median value for Net Income was -$21.5 million (2016), whereas its average is -$31.1 million.
  • Its Net Income has fluctuated over the past 5 years, first skyrocketed by 160.08% in 2015, then slumped by 368.53% in 2016.
  • EyePoint Pharmaceuticals' Net Income (Yearly) stood at -$13.4 million in 2014, then skyrocketed by 160.08% to $8.0 million in 2015, then plummeted by 368.53% to -$21.5 million in 2016, then rose by 14.21% to -$18.5 million in 2017, then plummeted by 187.64% to -$53.2 million in 2018.